泌尿外科指南

订阅

MedSci主页 / 所有栏目 / 泌尿外科指南

2022 ERKNet共识：胎儿下尿路梗阻的定义、诊断和管理

2022-02-08 欧洲罕见肾病参考网 Nat Rev Urol

泌尿外科下尿路梗阻胎儿下尿路梗阻

2022年2月，欧洲罕见肾病参考网(ERKNet)胎儿下尿路梗阻（LUTO）与肺发育不全和肾功能受损引起的高死亡率和产后发病率相关。本文主要针对产前检测的LUTO的临床定义、诊断以及管理提供共识建议。

中文标题：

2022 ERKNet共识：胎儿下尿路梗阻的定义、诊断和管理

英文标题：

Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group

发布机构：

欧洲罕见肾病参考网

发布日期：

2022-02-08

简要介绍：

2022年2月，欧洲罕见肾病参考网(ERKNet)胎儿下尿路梗阻（LUTO）与肺发育不全和肾功能受损引起的高死亡率和产后发病率相关。本文主要针对产前检测的LUTO的临床定义、诊断以及管理提供共识建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=s41585-022-00563-8.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5ae651c0023a9945, title=2022 ERKNet共识：胎儿下尿路梗阻的定义、诊断和管理, enTitle=Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group, guiderFrom=Nat Rev Urol, authorId=0, author=, summary=2022年2月，欧洲罕见肾病参考网(ERKNet)胎儿下尿路梗阻（LUTO）与肺发育不全和肾功能受损引起的高死亡率和产后发病率相关。本文主要针对产前检测的LUTO的临床定义、诊断以及管理提供共识建议。, cover=https://img.medsci.cn/2022210/1644500928069_1608702.png, journalId=0, articlesId=null, associationId=2386, associationName=欧洲罕见肾病参考网, associationIntro=欧洲罕见肾病参考网(ERKNet,European Rare Kidney Disease Reference Network), copyright=0, guiderPublishedTime=Tue Feb 08 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年2月，欧洲罕见肾病参考网(ERKNet)胎儿下尿路梗阻（LUTO）与肺发育不全和肾功能受损引起的高死亡率和产后发病率相关。本文主要针对产前检测的LUTO的临床定义、诊断以及管理提供共识建议。</span></p>, tagList=[TagDto(tagId=300, tagName=泌尿外科), TagDto(tagId=122789, tagName=下尿路梗阻), TagDto(tagId=122790, tagName=胎儿下尿路梗阻)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10784, appHits=74, showAppHits=0, pcHits=432, showPcHits=10709, likes=1, shares=16, comments=8, approvalStatus=1, publishedTime=Thu Feb 10 21:47:15 CST 2022, publishedTimeString=2022-02-08, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=dajiong, createdTime=Thu Feb 10 21:51:34 CST 2022, updatedBy=6415643, updatedName=凯晨, updatedTime=Wed Jan 03 12:20:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=s41585-022-00563-8.pdf)])
s41585-022-00563-8.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193312, encodeId=5c7c119331217, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Mon Feb 14 15:19:20 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192085, encodeId=3b35119208593, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:53 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192084, encodeId=390a119208439, content=学习了 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:48 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192241, encodeId=855f119224193, content=谢谢分享，帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00ef1386847, createdName=lds701, createdTime=Fri Feb 11 11:15:37 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192177, encodeId=6a5b11921e716, content=有帮助，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd446468880, createdName=ms9000001300771011, createdTime=Fri Feb 11 08:25:59 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-14 陌上咖啡

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193312, encodeId=5c7c119331217, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Mon Feb 14 15:19:20 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192085, encodeId=3b35119208593, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:53 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192084, encodeId=390a119208439, content=学习了 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:48 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192241, encodeId=855f119224193, content=谢谢分享，帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00ef1386847, createdName=lds701, createdTime=Fri Feb 11 11:15:37 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192177, encodeId=6a5b11921e716, content=有帮助，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd446468880, createdName=ms9000001300771011, createdTime=Fri Feb 11 08:25:59 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-10 一己怀

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193312, encodeId=5c7c119331217, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Mon Feb 14 15:19:20 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192085, encodeId=3b35119208593, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:53 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192084, encodeId=390a119208439, content=学习了 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:48 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192241, encodeId=855f119224193, content=谢谢分享，帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00ef1386847, createdName=lds701, createdTime=Fri Feb 11 11:15:37 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192177, encodeId=6a5b11921e716, content=有帮助，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd446468880, createdName=ms9000001300771011, createdTime=Fri Feb 11 08:25:59 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-10 一己怀

    学习了 学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193312, encodeId=5c7c119331217, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Mon Feb 14 15:19:20 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192085, encodeId=3b35119208593, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:53 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192084, encodeId=390a119208439, content=学习了 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:48 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192241, encodeId=855f119224193, content=谢谢分享，帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00ef1386847, createdName=lds701, createdTime=Fri Feb 11 11:15:37 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192177, encodeId=6a5b11921e716, content=有帮助，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd446468880, createdName=ms9000001300771011, createdTime=Fri Feb 11 08:25:59 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 lds701

    谢谢分享，帮助很大

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193312, encodeId=5c7c119331217, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Mon Feb 14 15:19:20 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192085, encodeId=3b35119208593, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:53 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192084, encodeId=390a119208439, content=学习了 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:52:48 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192241, encodeId=855f119224193, content=谢谢分享，帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00ef1386847, createdName=lds701, createdTime=Fri Feb 11 11:15:37 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192177, encodeId=6a5b11921e716, content=有帮助，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd446468880, createdName=ms9000001300771011, createdTime=Fri Feb 11 08:25:59 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 ms9000001300771011

    有帮助，谢谢

    0

相关指南

《慢性前列腺炎中西医结合多学科诊疗指南》解读

国家辅助生殖与优生工程技术研究中心 · 2021-12-20

《青少年精索静脉曲张诊治中国小儿泌尿外科专家共识》解读

暂未更新 · 2021-12-20

《腺性膀胱炎临床诊断和治疗中国专家共识》解读

航天中心医院泌尿外科 · 2021-12-20

男性下尿路症状诊断和治疗中国专家共识

中华医学会男科学分会男性下尿路症状诊断和治疗中国专家共识编写组 · 2021-12-20

2021 JUA 泌尿外科领域感染控制指南，包括泌尿道管理（修订后的第二版）

日本泌尿外科协会(JUA,Japanese Urological Association) · 2021-09-03

2021 多学科指南：妊娠期肾结石的管理

国外泌尿外科相关专家组（统称） · 2021-12-22